1141571

Keila Hoover, M.D. — FEI 3016483191

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 29, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)